Randomized Trial of Low-Dose Chemotherapy Added to Tamoxifen in Patients With Receptor-Positive and Lymph Node–Positive Breast Cancer
- 1 June 1999
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (6), 1701
- https://doi.org/10.1200/jco.1999.17.6.1701
Abstract
PURPOSE: To evaluate the outcome in patients with stage II hormone receptor–positive breast cancer treated or not treated with low-dose, short-term chemotherapy in addition to tamoxifen in terms of...Keywords
This publication has 31 references indexed in Scilit:
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patientsEuropean Journal Of Cancer, 1998
- Postmenopausal Patients with Node-Positive Resectable Breast CancerDrugs, 1993
- Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trialEuropean Journal Of Cancer, 1992
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centreBreast Cancer Research and Treatment, 1988
- ADJUVANT HORMONAL CHEMOTHERAPY IN EARLY BREAST CANCER: EARLY RESULTS FROM A CONTROLLED TRIALThe Lancet, 1984
- CONTROLLED TRIAL OF TAMOXIFEN AS ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCERThe Lancet, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958